Chronic pain is a global health concern that impairs physical and psychological well-being. Recently, nociplastic pain, characterized by the absence of overt inflammation or nerve injury, has gained attention as a distinct chronic pain condition. Central sensitization is considered a primary mechanism underlying nociplastic pain and the persistence of chronic pain states. Emerging evidence suggests that oxidative stress contributes to central sensitization, through increased neuronal excitability and glial activation; however, its role in nociplastic pain remains unclear. In this study, we investigated the involvement of oxidative stress in a prostaglandin E2 (PGE2)-induced hyperalgesic priming mouse model with features resembling nociplastic pain. Additionally, we examined the effects of modulating oxidative stress on pain progression using a silicon (Si)-based antioxidant agent. Repeated PGE2 administration induced mechanical allodynia and increased circulating reactive oxygen metabolites (d-ROMs), effects that were attenuated in mice treated with the Si-based agent. In the spinal dorsal horn, neuronal activity and astrocyte activation increased in the chronic pain model but not in mice treated with the Si-based agent. These findings support an association between systemic oxidative stress and spinal sensitization in this repeated PGE2-induced hyperalgesic priming model and provide insight into mechanisms underlying persistent pain that may share features with nociplastic pain.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: